Company intelligence / Profile preview

Basepaws

Los Angeles, California, United States

Ownership: Private
Employees: ~11
Development stage: Other

Overview

Basepaws has commercially launched DNA testing kits for cats and, as of 2023, for dogs. These kits provide pet owners with breed, trait, ancestry, and genetic disease risk information using NGS technology, and are supported by ongoing disease association research including a focus on feline diabetes mellitus. The company is expanding into canine genetics after pioneering the consumer feline genetic testing space.[2][4][6]

Therapeutic areas: NephrologyCardiovascularEndocrinologyInfectious DiseasesRare Diseases
Modalities: DeviceDiagnostics
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Basepaws.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Basepaws.

Explore the full profile